Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
KORU Medical Systems, Inc. (REPR)
|
Add to portfolio |
|
|
|
| Price: |
$2.98
| | Metrics |
| OS: |
45.6
|
M
| |
-29
|
% ROE
|
| Market cap: |
$136
|
M
| |
-42
|
% ROIC
|
|
Net cash:
|
$11.7
|
M
| |
$0.26
|
per share
|
|
EV:
|
$124
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($9.6)
|
M
| |
|
|
|
EBIT
|
($10.4)
|
M
| |
|
|
| EPS |
($0.18)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Feb-28-17 | Feb-29-16 |
| Revenues | 27.9 | 23.5 | 24.2 | 23.2 | 17.4 | 15.4 | 12.3 | 12.2 |
| Revenue growth | 18.8% | -2.8% | 4.4% | 33.5% | 12.4% | | 0.4% | 8.9% |
| Cost of goods sold | 12.5 | 9.7 | 9.2 | 8.3 | 6.5 | 6.2 | 4.7 | 4.6 |
| Gross profit | 15.4 | 13.8 | 14.9 | 14.9 | 10.8 | 9.3 | 7.6 | 7.6 |
| Gross margin | 55.1% | 58.6% | 61.8% | 64.1% | 62.3% | 60.0% | 61.6% | 62.1% |
| Selling, general and administrative | 20.6 | 17.9 | 12.0 | 9.8 | 8.2 | 7.7 | 7.8 | 5.9 |
| Research and development | 5.0 | 2.5 | 1.3 | 0.7 | 0.2 | 0.1 | 0.2 | 0.2 |
| EBITA | -10.8 | -7.0 | 1.3 | 4.0 | 2.1 | 1.1 | -0.7 | 1.2 |
| EBITA margin | -38.6% | -29.9% | 5.2% | 17.5% | 11.9% | 7.4% | -6.0% | 9.6% |
| Amortization of intangibles | | | 0.0 | | | | | |
| EBIT | -10.8 | -7.0 | 1.2 | 4.0 | 2.1 | 1.1 | -0.7 | 1.2 |
| EBIT margin | -38.6% | -29.9% | 5.0% | 17.5% | 11.9% | 7.4% | -6.0% | 9.6% |
| Pre-tax income | -10.7 | -6.4 | -1.2 | 0.7 | 1.2 | 1.2 | -0.8 | 1.1 |
| Income taxes | -2.0 | -1.8 | 0.0 | 0.1 | 0.3 | 0.4 | -0.2 | 0.4 |
| Tax rate | 18.9% | 28.3% | | 19.0% | 22.6% | 32.3% | 31.1% | 31.5% |
| Net income | -8.7 | -4.6 | -1.2 | 0.6 | 0.9 | 0.8 | -0.5 | 0.8 |
| Net margin | -31.0% | -19.4% | -5.0% | 2.4% | 5.2% | 5.3% | -4.4% | 6.4% |
| |
| Diluted EPS | ($0.19) | ($0.10) | ($0.03) | $0.01 | $0.02 | $0.02 | ($0.01) | $0.02 |
| Shares outstanding (diluted) | 45.0 | 44.4 | 41.9 | 39.1 | 38.9 | 38.4 | 37.9 | 38.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|